Darinaparsin
Darinaparsin
Darinaparsin (pronounced dah-rih-nuh-par-sin) is a chemotherapy drug used in the treatment of various types of cancer. It is a organic arsenic compound that is believed to work by interfering with the growth and spread of cancer cells in the body.
Etymology
The term "Darinaparsin" is derived from the chemical name for the drug, which is Zio-101 or S-dimethylarsino-glutathione. The name "Darinaparsin" was coined by the pharmaceutical company Ziopharm Oncology, which developed the drug.
Usage
Darinaparsin is used to treat various types of cancer, including cutaneous T-cell lymphoma, peripheral T-cell lymphoma, and certain types of leukemia. It is usually given by injection into a vein by a healthcare professional.
Side Effects
Common side effects of Darinaparsin include fatigue, nausea, vomiting, and decreased appetite. More serious side effects can include low blood cell counts, liver problems, and allergic reactions.
Related Terms
External links
- Medical encyclopedia article on Darinaparsin
- Wikipedia's article - Darinaparsin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski